These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 32730753)
41. YAP-TEAD signaling promotes basal cell carcinoma development via a c-JUN/AP1 axis. Maglic D; Schlegelmilch K; Dost AF; Panero R; Dill MT; Calogero RA; Camargo FD EMBO J; 2018 Sep; 37(17):. PubMed ID: 30037824 [TBL] [Abstract][Full Text] [Related]
42. Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma. Wong KF; Liu AM; Hong W; Xu Z; Luk JM Oncotarget; 2016 Nov; 7(47):77683-77695. PubMed ID: 27765911 [TBL] [Abstract][Full Text] [Related]
43. Palmitic acid dysregulates the Hippo-YAP pathway and inhibits angiogenesis by inducing mitochondrial damage and activating the cytosolic DNA sensor cGAS-STING-IRF3 signaling mechanism. Yuan L; Mao Y; Luo W; Wu W; Xu H; Wang XL; Shen YH J Biol Chem; 2017 Sep; 292(36):15002-15015. PubMed ID: 28698384 [TBL] [Abstract][Full Text] [Related]
44. Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1. Si Y; Ji X; Cao X; Dai X; Xu L; Zhao H; Guo X; Yan H; Zhang H; Zhu C; Zhou Q; Tang M; Xia Z; Li L; Cong YS; Ye S; Liang T; Feng XH; Zhao B Cancer Res; 2017 Sep; 77(18):4868-4880. PubMed ID: 28754671 [TBL] [Abstract][Full Text] [Related]
45. Lats1/2 Regulate Yap/Taz to Control Nephron Progenitor Epithelialization and Inhibit Myofibroblast Formation. McNeill H; Reginensi A J Am Soc Nephrol; 2017 Mar; 28(3):852-861. PubMed ID: 27647853 [TBL] [Abstract][Full Text] [Related]
46. Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma. Nallet-Staub F; Marsaud V; Li L; Gilbert C; Dodier S; Bataille V; Sudol M; Herlyn M; Mauviel A J Invest Dermatol; 2014 Jan; 134(1):123-132. PubMed ID: 23897276 [TBL] [Abstract][Full Text] [Related]
47. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway. Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277 [TBL] [Abstract][Full Text] [Related]
48. Dual role of YAP and TAZ in renewal of the intestinal epithelium. Imajo M; Ebisuya M; Nishida E Nat Cell Biol; 2015 Jan; 17(1):7-19. PubMed ID: 25531778 [TBL] [Abstract][Full Text] [Related]
49. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway. Toloczko A; Guo F; Yuen HF; Wen Q; Wood SA; Ong YS; Chan PY; Shaik AA; Gunaratne J; Dunne MJ; Hong W; Chan SW Cancer Res; 2017 Sep; 77(18):4921-4933. PubMed ID: 28720576 [TBL] [Abstract][Full Text] [Related]
50. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. Rashidian J; Le Scolan E; Ji X; Zhu Q; Mulvihill MM; Nomura D; Luo K Sci Signal; 2015 Feb; 8(363):ra14. PubMed ID: 25670202 [TBL] [Abstract][Full Text] [Related]
51. The Hippo pathway member Nf2 is required for inner cell mass specification. Cockburn K; Biechele S; Garner J; Rossant J Curr Biol; 2013 Jul; 23(13):1195-201. PubMed ID: 23791728 [TBL] [Abstract][Full Text] [Related]
52. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer. Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330 [TBL] [Abstract][Full Text] [Related]
53. Alternative Wnt Signaling Activates YAP/TAZ. Park HW; Kim YC; Yu B; Moroishi T; Mo JS; Plouffe SW; Meng Z; Lin KC; Yu FX; Alexander CM; Wang CY; Guan KL Cell; 2015 Aug; 162(4):780-94. PubMed ID: 26276632 [TBL] [Abstract][Full Text] [Related]
54. Effects of the hippo signaling pathway in human gastric cancer. Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801 [TBL] [Abstract][Full Text] [Related]
55. YAP/TAZ and Hedgehog Coordinate Growth and Patterning in Gastrointestinal Mesenchyme. Cotton JL; Li Q; Ma L; Park JS; Wang J; Ou J; Zhu LJ; Ip YT; Johnson RL; Mao J Dev Cell; 2017 Oct; 43(1):35-47.e4. PubMed ID: 28943241 [TBL] [Abstract][Full Text] [Related]
56. YAP triggers the Wnt/β-catenin signalling pathway and promotes enterocyte self-renewal, regeneration and tumorigenesis after DSS-induced injury. Deng F; Peng L; Li Z; Tan G; Liang E; Chen S; Zhao X; Zhi F Cell Death Dis; 2018 Feb; 9(2):153. PubMed ID: 29396428 [TBL] [Abstract][Full Text] [Related]
57. Dual Role of a C-Terminally Truncated Isoform of Large Tumor Suppressor Kinase 1 in the Regulation of Hippo Signaling and Tissue Growth. Matsui Y; Zhang Y; Paulson RF; Lai ZC DNA Cell Biol; 2019 Jan; 38(1):91-106. PubMed ID: 30461308 [TBL] [Abstract][Full Text] [Related]
58. Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration. Lu L; Finegold MJ; Johnson RL Exp Mol Med; 2018 Jan; 50(1):e423. PubMed ID: 29303509 [TBL] [Abstract][Full Text] [Related]
59. The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma. Kong F; Li Y; Hu E; Wang R; Wang J; Liu J; Zhang J; He D; Xiao X PLoS One; 2016; 11(12):e0167080. PubMed ID: 27907036 [TBL] [Abstract][Full Text] [Related]